Back to Evidence
Primary experimental recordPositive observation

PMC11990879::ACT014869

IV

Evidence text

Paper-level observation

Table 2: Compound IV, C. albicans MIC 32 mg/L.
tableConfidence: medium

Assay observation

Activity
Antimicrobial
Subtype
Antifungal
Measure
MIC
Comparator
=
Raw observation
32 other
Normalized measurement
=32 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Candida albicans
Assay method
Not reported by source
Sequence
CKRIVQRIKDFLRNH
Standardization
ready simple

Source publication

Anticandidal Activity of Lipopeptides Containing an LL-37-Derived Peptide Fragment KR12.

Molecules · 2025

Related peptide identities

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.